For those who have COPD and don’t know where to begin, the My COPD Checklist is your first port of call; one that can point ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM) is set to grow from $11.5 billion in ...

COPD cases among younger individuals are on the rise due to factors such as smoking, vaping, air pollution, and exposure to ...

In our rapidly evolving world, environmental pollutants pose an increasing threat to respiratory health. These invisible ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

Ted Koppel and his wife, Grace Anne Dorney Koppel — who was told she only had a few years left to live after her 2001 COPD ...

Good Samaritan will be having Lung Cancer Screening Days at the beginning of November. Those who are eligible include people ...

Opens in a new tab or window The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Personalized Care A nurse practitioner with NYU's pulmonary intervention team chronicles the NSCLC patient experience from diagnosis to ...

Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...